Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies

KAA Andersen, R Carhart‐Harris… - Acta Psychiatrica …, 2021 - Wiley Online Library
Objective To conduct a systematic review of modern‐era (post‐millennium) clinical studies
assessing the therapeutic effects of serotonergic psychedelics drugs for mental health …

Novel agents for the pharmacological treatment of alcohol use disorder

EM Burnette, SJ Nieto, EN Grodin, LR Meredith… - Drugs, 2022 - Springer
Alcohol use disorder (AUD) is a highly prevalent but severely under-treated disorder, with
only three widely-approved pharmacotherapies. Given that AUD is a very heterogeneous …

Cessation and reduction in alcohol consumption and misuse after psychedelic use

A Garcia-Romeu, AK Davis, F Erowid… - Journal of …, 2019 - journals.sagepub.com
Background: Meta-analysis of randomized studies using lysergic acid diethylamide (LSD) for
alcohol use disorder (AUD) showed large, significant effects for LSD efficacy compared to …

Incidence and progression of alcohol-associated liver disease after medical therapy for alcohol use disorder

AGL Vannier, JES Shay, V Fomin, SJ Patel… - JAMA Network …, 2022 - jamanetwork.com
Importance Alcohol-associated liver disease (ALD) is one of the most devastating
complications of alcohol use disorder (AUD), an increasingly prevalent condition. Medical …

Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients …

P Hollander, AK Gupta, R Plodkowski… - Diabetes …, 2013 - Am Diabetes Assoc
OBJECTIVE To assess the efficacy and safety of 32 mg naltrexone sustained-release
(SR)/360 mg bupropion SR (NB) in overweight/obese individuals with type 2 diabetes with …

Alcohol use in patients with chronic liver disease

D Fuster, JH Samet - New England Journal of Medicine, 2018 - Mass Medical Soc
Alcohol Use in Patients with Chronic Liver Disease | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

Meta‐analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

NC Maisel, JC Blodgett, PL Wilbourne… - …, 2013 - Wiley Online Library
Aims Although debates over the efficacy of oral naltrexone and acamprosate in treating
alcohol use disorders tend to focus on their global efficacy relative to placebo or their …

Acamprosate for alcohol dependence

S Rösner, A Hackl‐Herrwerth, S Leucht… - Cochrane Database …, 2010 - cochranelibrary.com
Background Alcohol dependence is among the main leading health risk factors in most
developed and developing countries. Therapeutic success of psychosocial programs for …

Opioid antagonists for alcohol dependence

S Roesner, A Hackl‐Herrwerth… - Cochrane database …, 2010 - cochranelibrary.com
Background Alcohol dependence belongs to the globally leading health risk factors.
Therapeutic success of psychosocial programs for relapse prevention is moderate and could …

[图书][B] Health psychology: An introduction to behavior and health

L Brannon, JA Updegraff, J Feist - 2018 - thuvienso.hoasen.edu.vn
an Introduction to Behavior and Health Page 1 Australia • Brazil • Mexico • Singapore • United
Kingdom • United States HealtH Psychology an Introduction to Behavior and Health NINtH …